Companies: 49,246 Total Market Cap: 132441797263938.02

Perrigo Company plc

NYSE: PRGO
Healthcare Drug Manufacturers - Specialty & Generic
Rank #3935
Market Cap 3.76 B
Volume 131,181
Price 27.36
Change (%) 0.59%
Country or region Ireland Ireland

Perrigo Company plc's latest marketcap:

3.76 B

As of 05/20/2025, Perrigo Company plc's market capitalization has reached $3.76 B. According to our data, Perrigo Company plc is the 3935th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.

Market Cap 3.76 B
Revenue (ttm) 4.34 B
Net Income (ttm) -180,200,000
Shares Out 137.48 M
EPS (ttm) -1.31
Forward PE 8.70
Ex-Dividend Date 05/30/2025
Earnings Date 05/07/2025
Market Cap Chart
Data Updated: 05/20/2025

Perrigo Company plc's yearly market capitalization.

Perrigo Company plc has seen its market value grow from $645.40 M to $3.76 B since 1998, representing a total increase of 482.80% and an annual compound growth rate (CAGR) of 6.91%.
Date Market Cap Change (%)
05/20/2025 $3.76 B 6.02%
12/31/2024 $3.51 B -19.56%
12/29/2023 $4.36 B -5%
12/30/2022 $4.59 B -11.8%
12/31/2021 $5.20 B -14.75%
12/31/2020 $6.10 B -13.19%
12/31/2019 $7.03 B 33.57%
12/31/2018 $5.26 B -57.12%
12/29/2017 $12.28 B 2.87%
12/30/2016 $11.93 B -43.67%
12/31/2015 $21.18 B -5.39%
12/31/2014 $22.39 B 54.74%
12/31/2013 $14.47 B 48.17%
12/31/2012 $9.77 B 7.71%
12/30/2011 $9.07 B 55.24%
12/31/2010 $5.84 B 60.58%
12/31/2009 $3.64 B 22.02%
12/31/2008 $2.98 B -8.9%
12/31/2007 $3.27 B 104.21%
12/29/2006 $1.60 B 15.06%
12/30/2005 $1.39 B 13.24%
12/31/2004 $1.23 B 11.97%
12/31/2003 $1.10 B 30.33%
12/31/2002 $842.80 M -3.1%
12/31/2001 $869.80 M 42.87%
12/29/2000 $608.80 M 3.75%
12/31/1999 $586.80 M -9.08%
12/31/1998 $645.40 M

Company Profile

About Perrigo Company plc

Perrigo Company plc is a leading provider of over-the-counter health and wellness solutions, serving customers in the United States, Europe, and internationally. Headquartered in Dublin, Ireland, the company was founded in 1887 and operates through two primary segments: Consumer Self-Care Americas and Consumer Self-Care International.

Product Portfolio

Perrigo offers a diverse range of self-care products, including:

  • Upper Respiratory: Cough suppressants, expectorants, and sinus/allergy relief products.
  • Nutrition: Infant formulas and nutritional beverages.
  • Digestive Health: Antacids, anti-diarrheal, and anti-heartburn solutions.
  • Pain & Sleep Aids: Pain relievers and fever reducers.
  • Oral Care: Toothbrushes, floss, whitening products, and more.
  • Healthy Lifestyle: Smoking cessation and well-being products.
  • Skin Care: Dermatological treatments, scar management, and lice solutions.
  • Women’s Health: Feminine hygiene and contraceptive products.
  • Vitamins & Supplements: Nutritional support for daily wellness.
  • Rare Diseases: Specialized treatments for uncommon conditions.

Brand Portfolio

Perrigo's products are sold under well-known brands, including:

  • Compeed
  • Dr. Fresh
  • Mederma
  • Prevacid24HR
  • Opill
  • NiQuitin
  • ACO
  • ellaOne

Distribution Channels

The company distributes its products through:

  • Retail drug, supermarket, and mass merchandise chains.
  • E-commerce platforms.
  • Wholesalers and pharmacies.
  • Drug and grocery retailers.
  • Para-pharmacies.

Additionally, Perrigo provides contract manufacturing services to support other brands in the health and wellness space.

Formerly known as Perrigo Company, the firm rebranded as Perrigo Company plc in December 2013.

Frequently Asked Questions

As of 05/20/2025, Perrigo Company plc (including the parent company, if applicable) has an estimated market capitalization of $3.76 B USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.

Perrigo Company plc global market capitalization ranking is approximately 3935 as of 05/20/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.

Stock Detail

Country or region Ireland
Founded 1887
IPO Date 12/16/1991
Employees 8,379
CEO Patrick Lockwood-Taylor
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
Address The Sharp Building, Hogan Place
Dublin, D02 TY74
Ireland
Website https://www.perrigo.com
People Also Watch
Zoetis
163.87 0.59%
Merck KGaA
131.89 0.59%
Haleon plc
546.86 0.59%
NSE-SUNPHARMA
19.96 0.59%